Victoza$526
Byetta$816
Wegovy$871
Trulicity$975
Ozempic$992
Rybelsus$995
Zepbound$1,052
Mounjaro$1,077
Saxenda$1,308
Victoza$526
Byetta$816
Wegovy$871
Trulicity$975
Ozempic$992
Rybelsus$995
Zepbound$1,052
Mounjaro$1,077
Saxenda$1,308

Mounjaro vs Zepbound

Compare Mounjaro and Zepbound on active ingredient, dosing schedule, FDA-approved use and pharmacy acquisition cost.

By Sam Reed · Founder and data leadVerified Aug 12, 2026

Mounjaro

Eli Lilly

Active ingredient
Tirzepatide
Form
INJECTION, SOLUTION
FDA-approved for
Type 2 diabetes
$1,077
lowest package, pharmacy acquisition cost

Zepbound

Eli Lilly

Active ingredient
Tirzepatide
Form
INJECTION, SOLUTION
FDA-approved for
Weight management, Obstructive sleep apnea
$1,052
lowest package, pharmacy acquisition cost

The short answer

Mounjaro and Zepbound both contain Tirzepatide. They differ in approved use and dose, not in active ingredient — which is why the choice usually comes down to what your prescriber can justify and what your plan covers.

Side by side

Costs are what a pharmacy pays to acquire each product, from CMS NADAC. Not a retail price, and not what you would pay.

Mounjaro
Zepbound
Lowest package cost
$1,077
$1,052
Active ingredient
Tirzepatide
Tirzepatide
Manufacturer
Eli Lilly
Eli Lilly
Form
INJECTION, SOLUTION
INJECTION, SOLUTION
FDA-approved for
Type 2 diabetes
Weight management, Obstructive sleep apnea
= better value on that rowScroll sideways on small screens — the first column stays pinned
Keep comparing
Data sources · cited with retrieval dates
  • CMS NADACNational Average Drug Acquisition Cost, weekly fileretrieved Aug 12, 2026
  • CMS Medicare Part DPrescriber public use file, by geography and drugretrieved Aug 12, 2026
  • CMS State Drug UtilizationQuarterly Medicaid prescription and reimbursement dataretrieved Aug 12, 2026

NADAC figures are pharmacy acquisition costs, not retail prices and not what you will pay. This content is educational and is not medical advice.